Cite

HARVARD Citation

    Potter, H. et al. (2021). Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease. Alzheimer's & dementia. 7 (1), p. n/a. [Online]. 
  
Back to record